Two Separable Aging Domains in Blood DNA Methylation Scores Developed for Cancer Research: Mitotic Replication and Early-Life Systemic Dysregulation
Genes · 2026
DOI: 10.3390/genes17091083 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genes, 2026. Verfasst von Katelyn N Austin und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Sociology, The University of Georgia, Athens, GA 30602, USA. Hauptthemen laut MEDLINE: DNA Methylation, Neoplasms, Mitosis, Aging. Die Arbeit nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, Child Health and Development Institute, NCI NIH HHS.
Abstract (Originalsprache)
Background/Objectives: DNA methylation (DNAm)-based aging measures are increasingly being used in biological aging, disease vulnerability, and cancer-related risk. However, it remains unclear whether these measures capture a single generalized aging process or separable biological domains relevant to cancer-relevant biological vulnerability.
Methods
Using data from the Family and Community Health Study (FACHS), we examine whether blood-based DNAm scores capture two distinct biological domains relevant to cancer susceptibility: a replication/mitotic domain, indexed by CellDRIFT, EpiTOC2, and MiAge, and an early-life systemic dysregulation domain, indexed by DunedinPACE, GrimAgeV2, and PhenoAge.
Results
Regression results showed clear domain specificity. CRP, BMI, alcohol methylation, and AHRR/cg05575921 were positively associated with the early-life systemic dysregulation domain but showed weak or null associations with the replication/mitotic domain. Cross-domain tests confirmed significantly stronger associations for the early-life systemic dysregulation domain for CRP, BMI, and alcohol methylation, with a marginal difference for AHRR/cg05575921. In contrast, telomere-related methylation and immune-cell composition showed a different pattern. DNAmTL was inversely associated with both domains and did not differ significantly across domains.
Conclusions
These findings suggest that blood-based DNAm aging measures do not reflect a single aging process. Instead, they distinguish at least two cancer-relevant methylation domains: one reflecting replication-driven mitotic aging and hematopoietic cell-turnover biology, and another reflecting early-life systemic dysregulation vulnerability linked to inflammation, metabolic risk, smoking methylation, and alcohol-related methylation. This two-domain framework may help clarify how blood DNAm profiles capture complementary biological processes relevant to cancer susceptibility and guide future studies of methylation-based cancer risk.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Sociology, The University of Georgia, Athens, GA 30602, USA.
ORCID-Profile: Katelyn N Austin, Man-Kit Lei
Förderung
- NHLBI NIH HHS
- Child Health and Development Institute
- NCI NIH HHS
- the National Heart, Lung, and Blood Institute
- NICHD NIH HHS
- National Institute of Child Health and Human Development
- National Cancer Institute
Zitieren
APA
Austin, K. N., & Lei, M. K. (2026). Two Separable Aging Domains in Blood DNA Methylation Scores Developed for Cancer Research: Mitotic Replication and Early-Life Systemic Dysregulation. Genes. https://doi.org/10.3390/genes17091083
Vancouver
Austin KN, Lei MK. Two Separable Aging Domains in Blood DNA Methylation Scores Developed for Cancer Research: Mitotic Replication and Early-Life Systemic Dysregulation. Genes. 2026. doi:10.3390/genes17091083
BibTeX
@article{Austin2026,
author = {Austin, Katelyn N and Lei, Man-Kit},
title = {Two Separable Aging Domains in Blood DNA Methylation Scores Developed for Cancer Research: Mitotic Replication and Early-Life Systemic Dysregulation},
journal = {Genes},
year = {2026},
doi = {10.3390/genes17091083}
}
EUVIMED